The high cost of GLP-1s is a key factor in this disparity
Now, more affordable oral GLP-1 medications and expanded Medicare coverage are expected to make obesity treatment more accessible in 2026
doi: 10.3389/fphar.2022.977385 Received 24 June 2022 Accepted 01 September 2022 Published 27 September 2022 Volume 13 - 2022 Edited by Sai Wang Seto, Hong Kong Polytechnic University, Hong Kong SAR, China Reviewed by Dominic Del Re, The State University of New Jersey, United States Karen R
bOther imaging modalities including contrast-enhanced (CE) computed tomography (CT) of neck, chest, abdomen with liver protocol, and bone scan, axial magnetic resonance imaging (MRI) depending on the tumor stage, serum calcitonin (150 pg/mL) and CEA